Won Seon-Hye, Suh Sang-Yeon, Yim Eunji, Ahn Hong-Yup
Department of Family Medicine, Dongguk University Ilsan Hospital, Goyang, Korea.
Department of Medicine, Dongguk University, Seoul, Korea.
Korean J Fam Med. 2022 Mar;43(2):125-131. doi: 10.4082/kjfm.21.0086. Epub 2022 Mar 17.
Many studies have assessed the risk factors for adverse drug reactions (ADRs) in elderly patients. However, most of these studies have focused on risk factors for ADRs, not serious ADRs (s-ADRs). s-ADRs are commonly found in hospitalized patients. s-ADRs warrant imminent but thorough investigations, given their critical impact on patient health. Therefore, this retrospective study aimed to assess the associated risk factors for s-ADRs in elderly hospitalized patients.
In-patients aged >65 years having ADRs during hospitalization at a university hospital in Korea between 2010 and 2012 were included. Medical professionals spontaneously reported ADRs using an electronic submission system at the study hospital. Further, all descriptions of ADRs were characterized and categorized through the screening of electronic medical records. We compared the characteristics of patients having s-ADRs with those of patients not having s-ADRs.
There were 353 cases of ADRs, 67 of which were s-ADRs. Patients taking more than eight concomitant drugs showed the highest odds ratio (OR, 11.99; 95% confidence interval [CI], 3.42-42.03). The ratio of aspartate aminotransferase (AST)/alanine aminotransferase (ALT) was also significantly related to s-ADRs (OR, 2.78; 95% CI, 1.33-5.81). The use of antibiotics (OR, 2.39; 95% CI, 1.13-5.02) and antineoplastics (OR, 4.17; 95% CI, 1.09-15.94) were significant risk factors.
Our findings highlight the importance of polypharmacy. Liver function tests (AST/ALT ratio) must be monitored carefully within high-risk groups for ADRs.
许多研究评估了老年患者药物不良反应(ADR)的危险因素。然而,这些研究大多关注ADR的危险因素,而非严重药物不良反应(s-ADR)。s-ADR在住院患者中很常见。鉴于s-ADR对患者健康的严重影响,需要立即进行全面调查。因此,这项回顾性研究旨在评估老年住院患者s-ADR的相关危险因素。
纳入2010年至2012年期间在韩国一家大学医院住院期间发生ADR的65岁以上患者。医学专业人员通过研究医院的电子提交系统自发报告ADR。此外,通过筛查电子病历对所有ADR描述进行特征分析和分类。我们比较了发生s-ADR的患者与未发生s-ADR的患者的特征。
共有353例ADR病例,其中67例为s-ADR。服用八种以上合并用药的患者显示出最高的比值比(OR,11.99;95%置信区间[CI],3.42 - 42.03)。天冬氨酸转氨酶(AST)/丙氨酸转氨酶(ALT)的比值也与s-ADR显著相关(OR,2.78;95%CI,1.33 - 5.81)。使用抗生素(OR,2.39;95%CI,1.13 - 5.02)和抗肿瘤药(OR,4.17;95%CI,1.09 - 15.94)是显著的危险因素。
我们的研究结果突出了多重用药的重要性。必须在ADR高危人群中仔细监测肝功能检查(AST/ALT比值)。